What is Competitive Landscape of Evolent Health Company?

Evolent Health Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What is the Competitive Landscape of Evolent Health?

The healthcare industry is transforming, moving towards value-based care where outcomes and efficiency are key. Evolent Health is a significant player in this shift, offering technology-enabled services to improve care and reduce costs. The company's substantial revenue growth, reaching $2.55 billion in 2024, highlights its importance in specialized care management.

Evolent Health, founded in 2011, aims to revolutionize healthcare delivery by enabling better clinical and financial outcomes through a value-driven system. The company's strategic consolidation of its various businesses into a single, specialty-focused entity has strengthened its position nationally among payers and providers.

Understanding the competitive landscape is crucial for Evolent Health's continued success. This involves analyzing key competitors and the broader industry trends that influence its future. A detailed Evolent Health Porter's Five Forces Analysis can provide deeper insights into these dynamics.

Evolent Health has established itself as a significant player in the healthcare solutions sector, focusing on technology-driven services for individuals with complex health needs. The company's core mission revolves around advancing value-based care, assisting health plans and providers in managing populations, enhancing care delivery, and simplifying administrative tasks. This positions Evolent Health within a dynamic market, facing competition from various healthcare IT and value-based care solution providers.

Core Business Focus

Evolent Health concentrates on technology-enabled services for complex conditions. Its primary aim is to support value-based care initiatives for health plans and providers.

Key Solution Areas

The company offers specialty care management, total cost of care management, and comprehensive administrative services. A strong emphasis is placed on high-value specialty areas like oncology and cardiology.

Financial Performance Overview

For the full year 2024, Evolent Health reported revenue of $2.55 billion, a 30.1% increase year-over-year. However, the company experienced a net loss of $93.5 million, with adjusted EBITDA at $160.5 million.

2025 Financial Outlook

Evolent anticipates 2025 revenue between $2.06 billion and $2.11 billion, factoring in a significant one-time revenue adjustment. Adjusted EBITDA is projected to be between $135 million and $165 million.

Evolent Health's market position is characterized by its extensive reach and strong client retention. The company serves a national network of prominent payers and providers, indicating a broad customer base. The increase in total lives on its platform to 84,778 thousand in Q1 2025 from 80,606 thousand in Q1 2024 highlights ongoing growth, particularly within its Specialty Technology and Services segment. A critical indicator of its market strength is the 100% partner contract retention rate among its top customers, who represent over 90% of its 2024 revenue. This demonstrates a high level of trust and satisfaction within its core relationships, a key factor in the competitive healthcare IT landscape.

Operational and Financial Metrics

Evolent Health's Q1 2025 revenue was $483.6 million, a year-over-year decrease attributed to contract changes, yet it exceeded analyst expectations. Adjusted EBITDA for the quarter was $36.9 million.

• As of March 31, 2025, the net debt to LTM Adjusted EBITDA ratio stood at 4.1x, up from 2.3x in Q1 2024.
• Total lives on the platform reached 84,778 thousand in Q1 2025.
• The company achieved 100% partner contract retention for its top customers in 2024.
• Evolent Health's business model is centered on providing value-based care solutions to health plans and providers.

Understanding Evolent Health's market position requires an analysis of its competitive landscape, including key Evolent Health competitors and how it stacks up against other Healthcare IT competitors. The company's focus on value-based care solutions and population health management companies places it in direct competition with entities that offer similar services. Evolent Health's growth strategy appears to be focused on deepening relationships with existing partners and expanding its service offerings within specialty care. The company's ability to maintain high customer retention is a significant competitive advantage, particularly when considering the complexities of the Target Market of Evolent Health. The Evolent Health industry analysis reveals a market driven by technological innovation and the increasing adoption of value-based payment models, presenting both opportunities and challenges for Evolent Health's market share and future outlook.

Evolent Health SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The competitive landscape for Evolent Health is characterized by a mix of large, established healthcare technology and services firms, as well as specialized value-based care enablement companies. Understanding these Evolent Health competitors is crucial for a comprehensive Evolent Health competitive analysis.

Key players in the direct competition space include Optum, a significant entity offering integrated solutions across pharmacy care, healthcare delivery, data analytics, and operations management. Oracle Health, formerly Cerner, is another major competitor, known for its healthcare information technology solutions. Change Healthcare also plays a role with its data and analytics-driven solutions impacting clinical, financial, administrative, and patient engagement aspects of healthcare.

Optum

A diversified health services and technology company with a broad range of offerings, including pharmacy benefits management, healthcare delivery, and data analytics.

Oracle Health (formerly Cerner)

A leading provider of healthcare information technology solutions, focusing on electronic health records and other clinical and operational systems.

Change Healthcare

Offers data and analytics-driven solutions aimed at improving efficiency and patient engagement across the healthcare ecosystem.

Aledade

A specialized company focused on enabling value-based care for physicians, assisting them in transitioning to risk-based payment models.

Lumeris

Another key player in value-based care enablement, providing platforms and services to help providers manage population health effectively.

Arcadia

Recognized as a top competitor, Arcadia offers population health management solutions and data analytics to support value-based care initiatives.

Broader Market Competition

Beyond direct rivals, Evolent Health also contends with companies in adjacent sectors. This includes specialized value-based care enablement firms such as Privia Health Group, which focuses on physician platforms. In the broader healthcare technology and data analytics arena, Health Catalyst provides data and analytics technology, while Verily develops precision health platforms. Indirect competition also arises from healthcare CRM software providers like Health Cloud, Halemind, and ScienceSoft, which offer customer relationship management features. Additionally, companies like Tabula Rasa HealthCare, serving pharmacists and prescribers, and Lash Group, providing patient support services, compete in specific niches. The Evolent Health market share is influenced by these diverse competitive pressures. Emerging players are also leveraging advanced technologies, and Evolent itself is adapting through strategic acquisitions, such as its planned acquisition of certain assets from Machinify to enhance its AI capabilities. This dynamic environment necessitates continuous innovation and strategic positioning, as detailed in the Growth Strategy of Evolent Health.

• Evolent Health market position is influenced by both large integrated players and specialized value-based care enablers.
• The company faces indirect competition from CRM providers and niche service companies.
• Strategic acquisitions, like the planned Machinify asset acquisition, are part of Evolent Health's growth strategy to stay competitive.
• The healthcare technology market is constantly evolving due to mergers, alliances, and new entrants.
• Evolent Health's ability to innovate and adapt is key to maintaining its competitive edge in the value-based care solutions market.

Evolent Health PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

Evolent Health has carved out a distinct market position by focusing on specialized technology, deep clinical expertise, and strong partner relationships. Its integrated technology platform is a cornerstone, providing clients with essential tools for managing care and building value-based business infrastructures. This platform is crucial for streamlining data and care workflows, especially within complex specialty care areas.

The company's commitment to innovation is evident in its strategic acquisitions, such as Machinify Auth, an AI-powered platform, and the development of solutions like its Oncology Navigation Solution. By May 2025, AI had been implemented across 200,000 reviews, with plans for full automation by 2026, aiming to serve 300,000 members through the Careology app. This focus on advanced technology and analytics drives operational efficiencies and enhances its value-based care solutions.

Integrated Technology Platform

Evolent Health's core technology provides clients with tools for effective care management and value-based business infrastructure, streamlining data and care workflows.

Specialized Clinical Expertise

The company possesses deep expertise in managing complex conditions, particularly in oncology, cardiology, and musculoskeletal markets, offering tailored solutions to reduce costs and improve outcomes.

AI and Advanced Analytics Deployment

Evolent Health is actively deploying AI, with 200,000 reviews processed by May 2025, aiming for full automation by 2026 to enhance efficiency and data insights.

Strong Partner Ecosystem and Loyalty

The company maintains high customer loyalty, achieving 100% contract retention among its top clients, representing over 90% of its 2024 revenue.

Strategic Growth and Financial Impact

Evolent Health's growth strategy includes securing new partnerships, such as adding 1.9 million members in 2025 from a New England health plan and five new revenue agreements in Q1 2025. Amendments to Performance Suite contracts are projected to deliver a significant annual improvement of $115 million in net income and adjusted EBITDA for 2025.

• Focus on condition-specific care as a 'first-mover advantage'.
• Leveraging data analytics for proactive patient care and risk adjustment.
• Continuous product development and strategic acquisitions.
• Proactive contract renegotiations to enhance financial performance.

Evolent Health Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

The broader healthcare industry is undergoing significant shifts, with value-based care (VBC) emerging as a dominant force. The U.S. VBC market is projected to expand from $4.01 trillion in 2024, growing at a compound annual growth rate of 7.4% through 2030. This trend is further bolstered by the Centers for Medicare & Medicaid Services' (CMS) objective for all Medicare beneficiaries to participate in VBC arrangements by 2030, with a notable pivot towards specialty care for future VBC initiatives. This evolving landscape directly aligns with the core business of companies like Evolent Health, positioning them to leverage these changes for growth.

Technological advancements, particularly in artificial intelligence (AI) and automation, are reshaping the competitive environment. A significant majority of healthcare executives anticipate an acceleration in the adoption of next-generation technologies in 2025, with a strong emphasis on technological investment. AI is recognized as a critical tool for enhancing predictive analytics, scaling VBC strategies, and optimizing revenue cycle management. Companies are actively integrating AI, with some aiming for full automation in key processes by 2026 to reduce administrative costs and improve operational efficiency. The integration of remote patient monitoring and telehealth also remains a vital trend, aiming to provide continuous health monitoring and reduce patient access barriers.

Industry Trends Shaping the Competitive Landscape

The healthcare industry is increasingly focused on value-based care, with the market expected to grow significantly. This shift emphasizes outcomes over volume, creating opportunities for companies that can effectively manage costs and improve patient health.

Technological Integration and Automation

Advancements in AI and automation are transforming healthcare operations. These technologies are crucial for predictive analytics, scaling VBC, and streamlining revenue cycles, driving efficiency and cost reduction.

Challenges in the Healthcare Market

Rising healthcare costs, particularly in areas like oncology, present a significant challenge. Additionally, factors such as Medicaid redeterminations and broader affordability concerns can impact membership levels and profitability for healthcare service providers.

Opportunities for Growth and Innovation

The growing demand for specialized healthcare solutions offers substantial expansion opportunities. Strategic contract renegotiations and securing new revenue agreements are key to mitigating cost volatility and driving growth.

Despite the promising trends, companies in this space face considerable headwinds. Elevated oncology costs, projected to grow by 12% in 2025, have impacted profit margins for some. Furthermore, the effects of Medicaid redeterminations and general healthcare affordability issues can put pressure on membership numbers and overall profitability. The investment in automation and AI initiatives, while strategic, can also lead to short-term financial impacts, such as adjusted EBITDA drag due to implementation costs. Changes in revenue recognition and contract conversions can also necessitate strategic adjustments to revenue projections. High leverage ratios, indicated by a net debt to LTM Adjusted EBITDA ratio of 4.1x in Q1 2025 for some entities, can also present financial challenges.

Strategic Positioning and Future Outlook

Companies are strategically navigating these challenges by focusing on specialty solutions and optimizing their financial structures. The aim is to achieve robust EBITDA growth through organic expansion and AI-driven efficiencies, while simultaneously working to reduce debt and enhance financial stability.

• Focus on expanding specialty care solutions.
• Implement AI and automation for margin improvement.
• Achieve 20% annual EBITDA growth targets.
• Deleverage debt by one turn per year.
• Enhance member and provider experience in specialty care.

Evolent Health Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔